Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

View source ↗

Summary

This clinical trial update notes a study evaluating ozanimod for steroid-dependent ulcerative colitis, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis (UC) | Status: RECRUITING